103 participants
Bortezomib in Treating Patients With Lymphoproliferative Disorders
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2015-12-08
- Start Date:
- 2001-06-30
- Completion:
- 2009-03-31
Conditions
- Recurrent Grade 1 Follicular Lymphoma
- Recurrent Grade 2 Follicular Lymphoma
- Recurrent Grade 3 Follicular Lymphoma
- Recurrent Mantle Cell Lymphoma
Interventions
- DRUG